Global development of resistance

Danish Medical Bulletin

Volumn 54, Issue 2, 2007, Pages 160-162

  Frimodt Møller, Niels ^a   Hammerum, Anette M ^a   Bagger Skjøt, Line ^a   Hessler, Jonas H R ^a   Brandt, Christian T ^a   Skov, Robert L ^a   Monnet, Dominique L ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; MACROLIDE; METALLO BETA LACTAMASE; METICILLIN; MONOBACTAM DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; DENMARK; DRUG USE; EGYPT; ENTEROBACTER INFECTION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GEOGRAPHIC DISTRIBUTION; GERMANY; GRAM NEGATIVE INFECTION; GREECE; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; NONHUMAN; PENICILLIN RESISTANCE; PSEUDOMONAS; PUBLIC HEALTH; SPAIN; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THAILAND; TUNISIA; TURKEY (REPUBLIC); UNITED STATES;

ANTI-BACTERIAL AGENTS; BIOMEDICAL RESEARCH; DENMARK; DRUG RESISTANCE; HUMANS; INTERNATIONAL COOPERATION; POPULATION SURVEILLANCE; WORLD HEALTH;

EID: 34249818775     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. European Antimicrobial Resistance Surveillance System (EARSS). Interactive database. www.rivm.nl/earss/July 2006.
2. Falagas ME, Bliziotis IA, Kasiakou SK et al. Outcome of infections due to pandrug-resistant Gram-negative bacteria. BMC Infect Dis 2005;5:24.
3. The Copenhagen Recommendations. Report from the invitational EU Conference on The Microbial Threat, Copenhagen, Denmark, September 1998. www.im.dk/publikationer/micro98/index.htm/July 2006.
4. Monnet DL. Antibiotic development and the changing role of the pharmaceutical industry. Int J Risk Safety Med 2005;17:133-45.
5. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87.
6. DANMAP - Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. Reports from 1996. www.dfvf.dk/default.asp?ID=9200/July 2006
7. Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC). Official Journal of the European Communities, L34/13-16.
8. www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed/April 2006.
9. www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=mesh/April 2006.
10. WHO Global Strategy for Containment of Antimicrobial Resistance. www.who.int/drugresistance/ WHO%20Global%20Strategy%20-%20Executive%20Summary%20- %20English%20version.pdf